How much funding has Sano Chemicals raised?

Sano Chemicals has disclosed $1.1M raised across 2 rounds.

Where is Sano Chemicals headquartered?

Sano Chemicals is headquartered in Bryan, US.

Sano Chemicals

Bryan, US · Texas corporation

Sano Chemicals is a clinical-stage drug development company creating new chemical entities (NCEs) as first-in-class treatments for antimicrobial-resistant fungi and bacteria, with additional research into cancer applications. It develops novel drug products aimed at infectious diseases where existing treatments have become ineffective.

Biotech Healthtech Longevity Medical Devices

Founders & leadership

James Leif SmithNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$1.1M disclosed across 2 rounds · 2024

▶$350KraisedMay 2024 · 1 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Frank AustinDirector
Stephen PruettDirector
Timothy HieberyDirector
James SmithExecutive Officer
Shi-En LuDirector

Amount sold: $350K
Placement agents: Elizabeth Hiebert
First sale: Apr 2024
Incorporated: Corporation, Texas
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$710KraisedJan 2024 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

James Leif SmithExecutive Officer

Offering amount: $710K
Amount sold: $710K
Minimum investment: $100K
Proceeds to insiders: $710K
First sale: Jan 2024
Incorporated: Corporation, Texas
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Knowde5 shared keywordsKnowde provides a data management platform for industrial businesses, specifically chemicals and ingredients, that uses AI to extract, structure, and harmonize fragmented master data from legacy systems. The platform includes a MDM system, customer experience portal, and marketplace to enable digital transformation, supply chain optimization, and sales enablement.

Nusano4 shared keywordsNusano produces medical radioisotopes for use in theranostic compounds and cancer treatment applications. The company serves the healthcare and oncology sectors by making radioisotopes available for targeted radiopharmaceutical therapies.

Companies competing with Sano Chemicals for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 4 SBIR/STTR awards

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase ISTTR	2020	$233.1K
National Institutes of Health (NIH)National Institutes of Health	Phase IISTTR	2019	$2.9M
National Institutes of Health (NIH)National Institutes of Health	Phase ISTTR	2017	$224.9K
National Institutes of Health (NIH)National Institutes of Health	Phase ISTTR	2016	$529.6K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Sano Chemicals do?: Sano Chemicals is a clinical-stage drug development company creating new chemical entities (NCEs) as first-in-class treatments for antimicrobial-resistant fungi and bacteria, with additional research into cancer applications. It develops novel drug products aimed at infectious diseases where existing treatments have become ineffective.
How much funding has Sano Chemicals raised?: Sano Chemicals has disclosed $1.1M raised across 2 rounds.
Where is Sano Chemicals headquartered?: Sano Chemicals is headquartered in Bryan, US.